Showing 34,642 results

The search for a cure

NIH researchers identify how two people controlled HIV after stopping treatment

Editor's pick
EurekAlert
31 October 2021
New & experimental HIV treatments

Merck's HIV program closer to regulator's doorstep with two phase 3 trials showing efficacy comparable to existing meds

Editor's pick
FierceBiotech
31 October 2021
Combatting stigma

Reducing HIV Misinformation in the South, One Person At A Time

Editor's pick
TheBody
31 October 2021
HIV treatment for children & young people

WHO Updates Pediatric Dosing Tool for Antiretroviral Medicines

Editor's pick
Medscape (requires free registration)
31 October 2021
Vaccinations & immunisations

Some immunocompromised people can receive a 4th Covid shot, CDC says

Editor's pick
NBC News
31 October 2021
Improving HIV care

Delivering HIV treatment via van: four reasons why it works

Editor's pick
Avert
31 October 2021
Pharmaceutical industry

Thailand’s switch to dolutegravir: more generic versions needed!

Editor's pick
Medicines Patent Pool
31 October 2021
Government, leadership & policy

How to end the AIDS epidemic in western and central Africa

Editor's pick
UNAIDS
31 October 2021
Government, leadership & policy

Amid Multiple Crises, Haiti's Efforts Against HIV Continue as Best They Can

Editor's pick
TheBody
31 October 2021
People who inject drugs

US: White People Who Inject Drugs Took More Risks, but More Black People Got HIV

Editor's pick
POZ
31 October 2021
Government, leadership & policy

Five questions about the HIV response in Nigeria

Editor's pick
UNAIDS
31 October 2021
Infant feeding

Half of Swiss mothers with HIV decide to breastfeed their baby when given the choice

News
31 October 2021
Lung disease

Lung function declines faster in people living with HIV

News
30 October 2021
Transgender people

Half of trans people attending English sexual health clinics took part in PrEP IMPACT study

News
29 October 2021

EACS 2021: L’abacavir provoca ancora gravi problemi cardiovascolari, Venerdì 29 ottobre 2021

October 2021

EACS 2021: O abacavir ainda causa sérios problemas cardiovasculares, Sexta-feira, 29 de outubro de 2021

October 2021

EACS 2021: Abacavir sigue provocando graves problemas cardiovasculares, Viernes, 29 de octubre de 2021

October 2021

EACS 2021: L'abacavir continue de causer des troubles cardiovasculaires graves, Vendredi 29 octobre 2021

October 2021

EACS 2021: Абакавир и серьезные сердечно-сосудистые осложнения, Пятница, 29 октября 2021 г.

October 2021

EACS 2021: Abacavir still causing serious cardiovascular problems, Friday 29 October 2021

October 2021
Violence

People living with HIV should be routinely asked about domestic abuse

News
28 October 2021
Side effects

Large international study finds 40% higher risk of serious cardiovascular problems in people taking abacavir since 2012

News
28 October 2021
Resistance

New cases of multi-drug resistant HIV becoming rarer in Europe

News
28 October 2021
PrEP programmes & uptake

First efficacy results from England's PrEP IMPACT Trial

News
28 October 2021